UnitedHealth Group's earnings call highlighted a robust performance for 2013, with revenues and net earnings showing significant growth, and the company maintained a strong financial position. Despite facing some pressures in 2014 from ACA implementation and Medicare funding actions, the management projected revenue growth to $128-$129 billion for the year, with strategic plans to offset these pressures. Furthermore, Optum's substantial revenue growth and positive future outlook, along with continued expansion in government and Medicaid markets, indicate resilience and potential growth. Overall, the positive financial health, strong operational readiness, and proactive strategies suggest a positive short-term impact on the stock.

[1]